MORGAN ALPHA: Open Payments
NPI 1710541933 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 13 payments from 8 companies in 2025. Trend: 2023 $322 · 2024 $118 · 2025 $432
Food & beverage: $257Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $181 |
| Lundbeck LLC | 4 | $92 |
| ABBVIE INC. | 2 | $47 |
| Genentech USA, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| ARGENX US, INC. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: PROLIA, VYEPTI, DALVANCE, Ocrevus Zunovo, OCTAGAM IMMUNE GLOBULIN (HUMAN), ULTOMIRIS, VYVGART HYTRULO, EVENITY.
Industry payments across LA — which companies pay providers there.
